S&P 500   3,941.63 (-0.18%)
DOW   32,063.96 (-0.13%)
QQQ   308.19 (-0.50%)
AAPL   158.50 (-0.27%)
MSFT   277.93 (+0.10%)
META   204.28 (+0.00%)
GOOGL   104.57 (-0.98%)
AMZN   97.15 (-1.58%)
TSLA   188.50 (-1.94%)
NVDA   264.50 (-2.73%)
NIO   8.96 (-3.34%)
BABA   86.01 (-0.59%)
AMD   97.26 (-3.01%)
T   18.50 (+0.22%)
F   11.39 (-0.26%)
MU   60.72 (-1.01%)
CGC   1.91 (+0.00%)
GE   91.59 (+0.00%)
DIS   93.30 (-2.64%)
AMC   4.44 (-0.67%)
PFE   40.20 (+0.05%)
PYPL   72.95 (+0.54%)
NFLX   326.30 (+1.85%)
S&P 500   3,941.63 (-0.18%)
DOW   32,063.96 (-0.13%)
QQQ   308.19 (-0.50%)
AAPL   158.50 (-0.27%)
MSFT   277.93 (+0.10%)
META   204.28 (+0.00%)
GOOGL   104.57 (-0.98%)
AMZN   97.15 (-1.58%)
TSLA   188.50 (-1.94%)
NVDA   264.50 (-2.73%)
NIO   8.96 (-3.34%)
BABA   86.01 (-0.59%)
AMD   97.26 (-3.01%)
T   18.50 (+0.22%)
F   11.39 (-0.26%)
MU   60.72 (-1.01%)
CGC   1.91 (+0.00%)
GE   91.59 (+0.00%)
DIS   93.30 (-2.64%)
AMC   4.44 (-0.67%)
PFE   40.20 (+0.05%)
PYPL   72.95 (+0.54%)
NFLX   326.30 (+1.85%)
S&P 500   3,941.63 (-0.18%)
DOW   32,063.96 (-0.13%)
QQQ   308.19 (-0.50%)
AAPL   158.50 (-0.27%)
MSFT   277.93 (+0.10%)
META   204.28 (+0.00%)
GOOGL   104.57 (-0.98%)
AMZN   97.15 (-1.58%)
TSLA   188.50 (-1.94%)
NVDA   264.50 (-2.73%)
NIO   8.96 (-3.34%)
BABA   86.01 (-0.59%)
AMD   97.26 (-3.01%)
T   18.50 (+0.22%)
F   11.39 (-0.26%)
MU   60.72 (-1.01%)
CGC   1.91 (+0.00%)
GE   91.59 (+0.00%)
DIS   93.30 (-2.64%)
AMC   4.44 (-0.67%)
PFE   40.20 (+0.05%)
PYPL   72.95 (+0.54%)
NFLX   326.30 (+1.85%)
S&P 500   3,941.63 (-0.18%)
DOW   32,063.96 (-0.13%)
QQQ   308.19 (-0.50%)
AAPL   158.50 (-0.27%)
MSFT   277.93 (+0.10%)
META   204.28 (+0.00%)
GOOGL   104.57 (-0.98%)
AMZN   97.15 (-1.58%)
TSLA   188.50 (-1.94%)
NVDA   264.50 (-2.73%)
NIO   8.96 (-3.34%)
BABA   86.01 (-0.59%)
AMD   97.26 (-3.01%)
T   18.50 (+0.22%)
F   11.39 (-0.26%)
MU   60.72 (-1.01%)
CGC   1.91 (+0.00%)
GE   91.59 (+0.00%)
DIS   93.30 (-2.64%)
AMC   4.44 (-0.67%)
PFE   40.20 (+0.05%)
PYPL   72.95 (+0.54%)
NFLX   326.30 (+1.85%)
NASDAQ:CERS

Cerus - CERS Price Target & Analyst Ratings

$2.86
+0.04 (+1.42%)
(As of 03/24/2023 12:27 PM ET)
Add
Compare
Today's Range
$2.77
▼
$2.93
50-Day Range
$2.65
▼
$3.34
52-Week Range
$2.36
▼
$5.95
Volume
336,612 shs
Average Volume
1.69 million shs
Market Capitalization
$507.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.88

Cerus Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 3 Analyst Ratings

Consensus Analyst Price Target

$4.88
70.45% Upside
High Prediction$6.00
Average Prediction$4.88
Low Prediction$3.75
TypeCurrent
3/24/22 to 3/24/23		1 Month Ago
2/22/22 to 2/22/23		3 Months Ago
12/24/21 to 12/24/22		1 Year Ago
3/24/21 to 3/24/22
Consensus Rating
Hold
Hold
Buy
N/A
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
 N/A
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
 N/A
Hold
2 Hold rating(s)
2 Hold rating(s)
0 Hold rating(s)
 N/A
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
 N/A
Consensus Price Target$4.88$4.88$6.00N/A
Predicted Upside70.45% Upside41.72% Upside48.51% UpsideN/A
Get Cerus Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CERS and its competitors with MarketBeat's FREE daily newsletter.

CERS Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CERS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cerus Stock vs. The Competition

TypeCerusMedical CompaniesS&P 500
Consensus Rating Score
2.33
2.64
2.47
Consensus RatingHoldBuyHold
Predicted Upside72.87% Upside1,987.28% Upside24.65% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/20/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeBuy ➝ Neutral
1/17/2023Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeOverweight ➝ Equal Weight$3.75+19.43%
12/5/2022Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating		B. Folkes
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOverweight
5/27/2020Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy$7.00 ➝ $8.00+34.23%
(Data available from 3/24/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












CERS Price Target - Frequently Asked Questions

What is Cerus's consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for Cerus stock is Hold based on the current 2 hold ratings and 1 buy rating for CERS. The average twelve-month price prediction for Cerus is $4.88 with a high price target of $6.00 and a low price target of $3.75. Learn more on CERS's analyst rating history.

Do Wall Street analysts like Cerus more than its competitors?

Analysts like Cerus less than other Medical companies. The consensus rating for Cerus is Hold while the average consensus rating for medical companies is Buy. Learn more on how CERS compares to other companies.

Is Cerus being downgraded by Wall Street analysts?

Over the previous 90 days, Cerus's stock had 2 downgrades by analysts.

Does Cerus's stock price have much upside?

According to analysts, Cerus's stock has a predicted upside of 41.72% based on their 12-month price targets.

What analysts cover Cerus?

Cerus has been rated by BTIG Research, and Stephens in the past 90 days.


Stock Ratings Reports and Tools

Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
Ratings for Popular Stocks:
This page (NASDAQ:CERS) was last updated on 3/24/2023 by MarketBeat.com Staff